Person › Details
Guy Braunstein (Actelion Ltd. (SIX: ATLN))
Braunstein, Guy (Actelion 201108 Head Clinical Development)
|Organisation||Actelion Ltd. (SIX: ATLN)|
Record changed: 2017-04-09
More documents for Guy Braunstein
-  Actelion Ltd.. (1/23/17). "Press Release: Actelion Announces Results of the MAESTRO Study with Macitentan in Patients with Pulmonary Arterial Hypertension Due to Eisenmenger Syndrome". Allschwil....
-  Actelion Ltd.. (7/7/16). "Press Release: Actelion to Enter Phase II Clinical Development with New Dual Orexin Receptor Antagonist in Patients with Insomnia". Allschwil....
To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to email@example.com and simply fill the subject line with the word »LSG newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)